First-in-human DR5 PET reveals insufficient DR5 expression in patients with gastrointestinal cancer.
Shujing WangHua ZhuYingjie LiJin DingFeng WangLixin DingXinyu WangJun ZhaoYan ZhangYunfeng YaoTong ZhouNan LiAiwen WuZhi YangPublished in: Journal for immunotherapy of cancer (2022)
89Zr-CTB006 PET/CT is capable of detecting DR5 expression in cancer patients and is a promising approach to screen patients with DR5 overexpression.